InsiderClue
← All stocks

ARS Pharmaceuticals, Inc.

SPRY Net buying
CIK 0001671858 #3013 in the set updated 19 Sep 2026
Bought (120 mo)
$109.79M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$121.40M
$47.85M on a plan · $23.16M straight out of an exercise
Sold at will
$50.39M
23 of 223 sales
Net
−$11.62M
+$59.39M against sales at will

By person

25 insiders · 261 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
Director
$44.72M (6)
—
+$44.72M
9,958,073
$99.58M
—
Lowenthal Richard E
PRESIDENT AND CEO
—
$23.82M (73) scheduled
−$23.82M
5,523,683
$55.24M
—
Flynn James E
10% owner
—
$23.81M (10)
−$23.81M
4,887,254
$48.87M
−21.1%
Tanimoto Sarina
CHIEF MEDICAL OFFICER
—
$23.80M (74) scheduled
−$23.80M
4,680,959
$46.81M
—
ORBIMED ADVISORS LLC entity
Director
$28.10M (3)
$12.59M (5)
+$15.51M
8,740,888
$87.41M
+782.0%
Thompson Peter A.
Director
$28.10M (3)
$12.59M (5)
+$15.51M
8,740,888
$87.41M
+782.0%
Shawver Laura
Director
—
$8.63M (23) scheduled
−$8.63M
210,346
$2.10M
+163.3%
Chakma Justin
Chief Business Officer
—
$8.56M (13) scheduled
−$8.56M
0
$0.00
—
Schroeder Thilo
Director
$5.00M (1)
—
+$5.00M
1,910,029
$19.10M
—
ROOT JONATHAN D
Director
$2.04M (3)
—
+$2.04M
2,269,417
$22.69M
+4.5%
Dorsey Brian
Chief Operating Officer
—
$1.82M (5) scheduled
−$1.82M
10,789
$107.89K
0.0%
SAUNDERS BRENT L
Director
—
$1.71M (1) scheduled
−$1.71M
0
$0.00
—
Karas Eric
Chief Commercial Officer
—
$1.31M (8) scheduled
−$1.31M
12,176
$121.76K
0.0%
Scott Kathleen D.
Chief Financial Officer
$51.51K (1)
$1.29M (4) scheduled
−$1.24M
18,292
$182.92K
+82.2%
Fitzpatrick Alexander A
Chief Legal Officer
$319.95K (2)
$1.49M (2) scheduled
−$1.17M
90,910
$909.10K
+728.3%
Presidio Management Group XII, L.L.C. entity
10% owner
$1,000.00K (1)
—
+$1,000.00K
2,221,798
$22.22M
—
Piazza Jonathan
Chief Financial Officer
$249.98K (1)
—
+$249.98K
69,225
$692.25K
+2,809%
CAPPS VICKIE L
Director
$199.98K (1)
—
+$199.98K
61,576
$615.76K
+18.3%
Hawkinson Russ
Sr. Vice President of Finance
$5.00K (1)
—
+$5.00K
37,251
$372.51K
+3,062%
Shah Pratik
Director
—
—
—
4,474,554
$44.75M
—
Dadoo Rajeev
Director
—
—
—
3,009,677
$30.10M
—
Alexandria Venture Investments, LLC entity
10% owner
—
—
—
699,412
$6.99M
—
Kelly Michael
Director
—
—
—
83,225
$832.25K
—
Odegard Valerie
President and CSO
—
—
—
61,639
$616.39K
—
Hunder Naomi
Chief Medical Officer
—
—
—
54,427
$544.27K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

51
Insider
Date
Role
Action
Shares
Price
Amount
Karas Eric
12 Jun 2026
Chief Commercial Officer
Sold after exercise
25,000
$10.00
$250.00K
Dorsey Brian
13 Nov 2025
Chief Operating Officer
Sold after exercise
21,828
$8.71
$190.05K
Chakma Justin
12 Nov 2025
Chief Business Officer
Sold after exercise
136,380
$8.86
$1.21M
Chakma Justin
12 Nov 2025
Chief Business Officer
Sold after exercise
30,000
$8.91
$267.36K
Scott Kathleen D.
21 Aug 2025
Chief Financial Officer
Sold after exercise
12,500
$15.00
$187.50K
Karas Eric
1 Jul 2025
Chief Commercial Officer
Sold after exercise
15,000
$16.99
$254.86K
Karas Eric
18 Jun 2025
Chief Commercial Officer
Sold after exercise
15,000
$16.00
$240.00K
Scott Kathleen D.
20 May 2025
Chief Financial Officer
Sold after exercise
50,000
$14.10
$705.17K
SAUNDERS BRENT L
20 May 2025
Director
Sold after exercise
120,000
$14.25
$1.71M
Fitzpatrick Alexander A
20 May 2025
Chief Legal Officer
Sold after exercise
102,969
$14.10
$1.45M
Shawver Laura
7 Apr 2025
Director
Sold after exercise
50,002
$12.30
$615.07K
Karas Eric
20 Mar 2025
Chief Commercial Officer
Sold after exercise
10,000
$14.00
$140.00K
Shawver Laura
6 Mar 2025
Director
Sold after exercise
49,600
$11.21
$556.05K
Shawver Laura
5 Mar 2025
Director
Sold after exercise
400
$11.00
$4.40K
Shawver Laura
3 Feb 2025
Director
Sold after exercise
50,000
$12.31
$615.57K
Shawver Laura
6 Jan 2025
Director
Sold after exercise
50,000
$11.10
$555.07K
Chakma Justin
13 Dec 2024
Chief Business Officer
Sold after exercise
27,272
$12.06
$328.97K
Dorsey Brian
12 Dec 2024
Chief Operating Officer
Sold after exercise
25,000
$12.30
$307.43K
Chakma Justin
12 Dec 2024
Chief Business Officer
Sold after exercise
117,333
$12.27
$1.44M
Dorsey Brian
11 Dec 2024
Chief Operating Officer
Sold after exercise
15,000
$12.43
$186.43K
Chakma Justin
10 Dec 2024
Chief Business Officer
Sold after exercise
50,000
$13.15
$657.63K
Chakma Justin
6 Dec 2024
Chief Business Officer
Sold after exercise
50,000
$14.23
$711.62K
Chakma Justin
5 Dec 2024
Chief Business Officer
Sold after exercise
49,640
$14.13
$701.64K
Karas Eric
4 Dec 2024
Chief Commercial Officer
Sold after exercise
6,283
$14.00
$87.96K
Shawver Laura
4 Dec 2024
Director
Sold after exercise
14,772
$13.75
$203.11K
Chakma Justin
4 Dec 2024
Chief Business Officer
Sold after exercise
45,000
$13.95
$627.94K
Shawver Laura
3 Dec 2024
Director
Sold after exercise
87,984
$13.26
$1.17M
Chakma Justin
3 Dec 2024
Chief Business Officer
Sold after exercise
45,000
$13.19
$593.40K
Karas Eric
2 Dec 2024
Chief Commercial Officer
Sold after exercise
3,717
$14.11
$52.46K
Shawver Laura
2 Dec 2024
Director
Sold after exercise
901
$14.34
$12.92K
Shawver Laura
2 Dec 2024
Director
Sold after exercise
96,343
$13.55
$1.31M
Chakma Justin
2 Dec 2024
Chief Business Officer
Sold after exercise
45,000
$13.67
$615.22K
Scott Kathleen D.
16 Oct 2024
Chief Financial Officer
Sold after exercise
12,500
$16.00
$200.00K
Karas Eric
18 Sep 2024
Chief Commercial Officer
Sold after exercise
10,000
$14.00
$140.00K
Scott Kathleen D.
20 Aug 2024
Chief Financial Officer
Sold after exercise
12,500
$16.00
$200.00K
Dorsey Brian
20 Aug 2024
Chief Operating Officer
Sold after exercise
50,000
$15.00
$750.00K
Karas Eric
19 Aug 2024
Chief Commercial Officer
Sold after exercise
10,000
$14.00
$140.00K
Dorsey Brian
13 Aug 2024
Chief Operating Officer
Sold after exercise
30,000
$13.00
$390.00K
Shawver Laura
1 Sep 2023
Director
Sold after exercise
100,000
$7.71
$770.52K
Shawver Laura
4 Aug 2023
Director
Sold after exercise
18,897
$7.06
$133.47K
Shawver Laura
3 Aug 2023
Director
Sold after exercise
26,107
$7.01
$183.02K
Shawver Laura
2 Aug 2023
Director
Sold after exercise
36,281
$7.09
$257.26K
Shawver Laura
1 Aug 2023
Director
Sold after exercise
18,715
$7.19
$134.58K
Shawver Laura
7 Jul 2023
Director
Sold after exercise
8,858
$6.36
$56.37K
Shawver Laura
6 Jul 2023
Director
Sold after exercise
33,510
$6.34
$212.55K
Shawver Laura
5 Jul 2023
Director
Sold after exercise
31,112
$6.41
$199.55K
Shawver Laura
3 Jul 2023
Director
Sold after exercise
26,520
$6.73
$178.35K
Shawver Laura
2 Jun 2023
Director
Sold after exercise
26,941
$6.95
$187.24K
Shawver Laura
1 Jun 2023
Director
Sold after exercise
73,059
$6.80
$496.80K
Shawver Laura
9 May 2023
Director
Sold after exercise
42,900
$5.31
$227.80K
Shawver Laura
8 May 2023
Director
Sold after exercise
57,100
$6.16
$351.74K
Showing 250 of 261 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 229
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 17
Sales on a Rule 10b5-1 plan 149
Sales straight out of an exercise 51
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 84,407,624
History held since 7 Dec 2020